It was announced on Monday that the agreement has been signed for the development, manufacturing, commercialisation, and distribution of Toctino(r)(alitretinoin) by Stiefel.
You must be logged in to view the whole article.
Click here if you require signing up
AstraZeneca's new global R&D centre and corporate headquarters to be sited in Cambridge, UK
Isotechnika secures additional govt funding for NICAM project
Mei Pharma begins Phase II study of pracinostat in myelodysplastic syndrome
BioPorto expands animal NGAL product portfolio
GenMark Diagnostics cuts financial outlook for 2013
Immunicum secures extended SME status in EU
FDA accepts for review IntelGenx's NDA for VersaFilm anti-migraine oral thin film
Ipsen reports mixed Phase IIIb data for Somatuline Autogel 120mg for acromegaly
Teva Pharmaceutical Industries Ltd to acquire MicroDose Therapeutx for USD40m at closing
Perrigo Company announces addition of USD93m ophthalmic ointment and solution products portfolio
Transition Therapeutics Inc reports exercise of rights to TT-401 by Eli Lilly and Company
Rexahn Pharmaceuticals Inc wins patent for novel anti-cancer compounds in the US
LabCorp adds Roche's COBAS AmpliPrep/COBAS TaqMan HCV Test to offering